Mr. Adrian Mendes reports

PERIMETER MEDICAL IMAGING AI ANNOUNCES ANNUAL MEETING RESULTS, AMENDMENT TO INCENTIVE PLAN AND CHANGES TO BOARD OF DIRECTORS

Perimeter Medical Imaging AI Inc. has released results from its annual general and special meeting of shareholders that was held today.

All of the matters put forward before the shareholders, as set out in the company's management information circular dated Nov. 28, 2025, were approved by the requisite majority of votes cast at the meeting.

Director election and resignation

At the meeting, the shareholders of the company elected the following individuals to the board of directors of the company to hold office until the next annual meeting of shareholders or until their successors are duly elected or appointed: Suzanne M. Foster, Aaron Davidson, Joshua G. Vose, Michelle Caron and Adrian Mendes.

Following the meeting, Ms. Caron resigned from the board and informed the company that, due to personal reasons, she would be unable to serve as a director of the company for the time being.

The company's board is currently composed of Ms. Foster, Mr. Davidson, Mr. Vose and Mr. Mendes.

"Due to unforeseen personal reasons, Michelle was unable to join the board following this year's annual meeting. During our extensive vetting process, Michelle distinguished herself significantly above the other candidates, and I look forward to pursuing future opportunities for Michelle with the company when the time is right," said Perimeter's chief executive officer Mr. Mendes. "Our board remains aligned as we execute on our strategy to advance the AI-powered B-Series toward regulatory approval in the first half of 2026, which we believe represents a key inflection point for the company."

Appointment of auditor

The company's shareholders approved the appointment of KPMG LLP as the auditor for the company to hold office until the close of the next annual meeting or until its successor is duly appointed, at such remuneration as may be determined by the board.

Amendment to stock option plan

The company's shareholders approved an amendment to the company's omnibus equity incentive plan to increase the number of common shares in the capital of the company issuable upon exercise or conversion of the securities issued under the incentive plan, from 12,834,531 to 22,272,662 shares, being the number equal to 20 per cent of the issued and outstanding common shares as at Nov. 28, 2025, or such other number of common shares as may be permitted by the TSX Venture Exchange.

The full text of the incentive plan is attached to the information circular as Schedule A, a copy of which can be found on the company's SEDAR+ profile. The amendment to the incentive plan remains subject to the final approval of the exchange.

About Perimeter Medical Imaging AI Inc.

Based in Toronto, Canada, and Dallas, Tex., Perimeter Medical Imaging AI is a medical technology company driven to transform cancer surgery with ultrahigh-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the United States, its Food and Drug Administration-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents its next-generation artificial intelligence technology that has recently been evaluated in a pivotal clinical trial, with support from a grant of up to $7.4-million (U.S.) awarded by the Cancer Prevention and Research Institute of Texas. The company's ticker symbol PINK is a reference to the pink ribbons used during breast cancer awareness month.

Perimeter B-Series OCT is not available for sale in the United States. Perimeter S-Series OCT has 510(k) clearance under a general indication and has not been evaluated by the U.S. FDA specifically for use in breast tissue, breast cancer, other types of cancer, margin evaluation and reducing re-excision rates. The safety and effectiveness of these uses have not been established.

We seek Safe Harbor.